Compare · CCXI vs HCAC
CCXI vs HCAC
Side-by-side comparison of Churchill Capital Corp XI (CCXI) and Hall Chadwick Acquisition Corp (HCAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCXI and HCAC operate in Blank Checks (Finance), so they compete in similar markets.
- CCXI has been more active in the news (49 items in the past 4 weeks vs 4 for HCAC).
- CCXI has more recent analyst coverage (8 ratings vs 0 for HCAC).
Churchill Capital Corp XI
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibitor for the treatment of anti-neutrophil cytoplasmic autoantibody-associated vasculitis; and completed Phase II clinical trial for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. The company is also developing CCX559, an orally-administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally-administered inhibitor of the chemokine receptor CC9, which has completed Phase I clinical trial or the treatment of inflammatory bowel disease. In addition, it develops CCX587 for the treatment of TH17 driven diseases. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California.
Latest CCXI
- Chief Operating Officer Hunter Jennifer was granted 3,220,699 stock options (SEC Form 4)
- Officer Lang Anastasia was granted 2,760,599 stock options (SEC Form 4)
- Director Shelton Damion was granted 9,938,151 shares (SEC Form 4)
- Chief Technology Officer Velagapudi Prasanna was granted 3,680,797 stock options (SEC Form 4)
- Chief Financial Officer Beer Michael Thomas was granted 2,576,560 shares (SEC Form 4)
- Chief Executive Officer Johnson Margaret L was granted 347,790 shares (SEC Form 4)
- Chief Robot Officer Hurst Jonathan was granted 12,422,709 shares (SEC Form 4)
- Chief Hardware Officer Marroquin Marco was granted 2,300,498 stock options (SEC Form 4)
- President Diez Daniel was granted 3,220,699 stock options (SEC Form 4)
- SEC Form 3 filed by new insider Hunter Jennifer
Latest HCAC
- SEC Form 425 filed by Hall Chadwick Acquisition Corp
- Hall Chadwick Acquisition Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- REEcycle Holdings, Inc. and Hall Chadwick Acquisition Corp. Announce SEC Effectiveness of Registration Statement, Advancing Proposed Nasdaq Listing
- Hall Chadwick Acquisition Corp. and REEcycle Unveil Proposed Board Featuring Former Senior U.S. Intelligence and Energy Officials to Advance America’s Rare Earth Supply Chain
- SEC Form 425 filed by Hall Chadwick Acquisition Corp
- Hall Chadwick Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- Hall Chadwick Acquisition Corp. and REEcycle Holdings, Inc. Announce Filing of Registration Statement on Form S-4 and Release Updated Investor Presentation
- Amendment: SEC Form 10-K/A filed by Hall Chadwick Acquisition Corp
- Amendment: SEC Form 10-Q/A filed by Hall Chadwick Acquisition Corp
- Amendment: SEC Form 10-Q/A filed by Hall Chadwick Acquisition Corp